An Updated Review on the Role of Single Nucleotide Polymorphisms in COVID-19 Disease Severity: A Global Aspect

World Health Organization. Transmission of SARS-CoV-2: Implications for Infection Prevention Precautions. Available from: https://www.who.int/news-room/commentaries/detail/transmission-of-sars-cov-2-implications-for-infection-prevention-precautions (Accessed April 13, 2021).

World Health Organization. WHO-convened Global Study of Origins of SARS-CoV-2: China Part. Available from: https://www.who.int/publications/i/item/who-convened-global-study-of-origins-of-sars-cov-2-china-part (Accessed April 13, 2021).

Richardson, S.; Hirsch, J.S.; Narasimhan, M.; Crawford, J.M.; McGinn, T.; Davidson, K.W.; Barnaby, D.P.; Becker, L.B.; Chelico, J.D.; Cohen, S.L.; Cookingham, J.; Coppa, K.; Diefenbach, M.A.; Dominello, A.J.; Duer-Hefele, J.; Falzon, L.; Gitlin, J.; Hajizadeh, N.; Harvin, T.G.; Hirschwerk, D.A.; Kim, E.J.; Kozel, Z.M.; Marrast, L.M.; Mogavero, J.N.; Osorio, G.A.; Qiu, M.; Zanos, T.P. Presenting Characteris-tics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA, 2020, 323(20), 2052-2059.
[http://dx.doi.org/10.1001/jama.2020.6775] [PMID: 32320003]

Grasselli, G.; Zangrillo, A.; Zanella, A.; Antonelli, M.; Cabrini, L.; Castelli, A.; Cereda, D.; Coluccello, A.; Foti, G.; Fumagalli, R.; Iotti, G.; Latronico, N.; Lorini, L.; Merler, S.; Natalini, G.; Piatti, A.; Ranieri, M.V.; Scandroglio, A.M.; Storti, E.; Cecconi, M.; Pesenti, A. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA, 2020, 323(16), 1574-1581.
[http://dx.doi.org/10.1001/jama.2020.5394] [PMID: 32250385]

van der Made, C.I.; Simons, A.; Schuurs-Hoeijmakers, J.; van den Heuvel, G.; Mantere, T.; Kersten, S.; van Deuren, R.C.; Steehouwer, M.; van Reijmersdal, S.V.; Jaeger, M.; Hofste, T.; Astuti, G.; Corominas Galbany, J.; van der Schoot, V.; van der Hoeven, H.; Hagmolen Of Ten Have, W.; Klijn, E.; van den Meer, C.; Fiddelaers, J.; de Mast, Q.; Bleeker-Rovers, C.P.; Joosten, L.A.B.; Yntema, H.G.; Gilissen, C.; Nelen, M.; van der Meer, J.W.M.; Brunner, H.G.; Netea, M.G.; van de Veerdonk, F.L.; Hoischen, A. Presence of genetic variants among young men with severe COVID-19. JAMA, 2020, 324(7), 663-673.
[http://dx.doi.org/10.1001/jama.2020.13719] [PMID: 32706371]

Zhou, F.; Yu, T.; Du, R.; Fan, G.; Liu, Y.; Liu, Z.; Xiang, J.; Wang, Y.; Song, B.; Gu, X.; Guan, L.; Wei, Y.; Li, H.; Wu, X.; Xu, J.; Tu, S.; Zhang, Y.; Chen, H.; Cao, B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retro-spective cohort study. Lancet, 2020, 395(10229), 1054-1062.
[http://dx.doi.org/10.1016/S0140-6736(20)30566-3] [PMID: 32171076]

Ackermann, M.; Verleden, S.E.; Kuehnel, M.; Haverich, A.; Welte, T.; Laenger, F.; Vanstapel, A.; Werlein, C.; Stark, H.; Tzankov, A.; Li, W.W.; Li, V.W.; Mentzer, S.J.; Jonigk, D. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N. Engl. J. Med., 2020, 383(2), 120-128.
[http://dx.doi.org/10.1056/NEJMoa2015432] [PMID: 32437596]

Bilaloglu, S.; Aphinyanaphongs, Y.; Jones, S.; Iturrate, E.; Hochman, J.; Berger, J.S. Thrombosis in hospitalized patients with COVID-19 in a New York City health system. JAMA, 2020, 324(8), 799-801.
[http://dx.doi.org/10.1001/jama.2020.13372] [PMID: 32702090]

Docherty, A.B.; Harrison, E.M.; Green, C.A.; Hardwick, H.E.; Pius, R.; Norman, L.; Holden, K.A.; Read, J.M.; Dondelinger, F.; Carson, G.; Merson, L.; Lee, J.; Plotkin, D.; Sigfrid, L.; Halpin, S.; Jackson, C.; Gamble, C.; Horby, P.W.; Nguyen-Van-Tam, J.S.; Ho, A.; Russell, C.D.; Dunning, J.; Openshaw, P.J.; Baillie, J.K.; Semple, M.G. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ, 2020, 369, m1985.
[http://dx.doi.org/10.1136/bmj.m1985] [PMID: 32444460]

Salian, V.S.; Wright, J.A.; Vedell, P.T.; Nair, S.; Li, C.; Kandimalla, M.; Tang, X.; Carmona Porquera, E.M.; Kalari, K.R.; Kandimalla, K.K. COVID-19 transmission, current treatment, and future therapeutic strategies. Mol. Pharm., 2021, 18(3), 754-771.
[http://dx.doi.org/10.1021/acs.molpharmaceut.0c00608] [PMID: 33464914]

Skevaki, C.; Pararas, M.; Kostelidou, K.; Tsakris, A.; Routsias, J.G. Single nucleotide polymorphisms of Toll-like receptors and suscepti-bility to infectious diseases. Clin. Exp. Immunol., 2015, 180(2), 165-177.
[http://dx.doi.org/10.1111/cei.12578] [PMID: 25560985]

Trejo-de la O. A.; Hernández-Sancén, P.; Maldonado-Bernal, C. Relevance of single-nucleotide polymorphisms in human TLR genes to infectious and inflammatory diseases and cancer. Genes Immun., 2014, 15(4), 199-209.
[http://dx.doi.org/10.1038/gene.2014.10] [PMID: 24622688]

Nogales, A.L.; DeDiego, M. Host single nucleotide polymorphisms modulating influenza A virus disease in humans. Pathogens, 2019, 8(4), 168.
[http://dx.doi.org/10.3390/pathogens8040168] [PMID: 31574965]

Kominato, Y.; Sano, R.; Takahashi, Y.; Hayakawa, A.; Ogasawara, K. Human ABO gene transcriptional regulation. Transfusion, 2020, 60(4), 860-869.
[http://dx.doi.org/10.1111/trf.15760] [PMID: 32216153]

Kumar, N.; Kapoor, A.; Kalwar, A.; Narayan, S.; Singhal, M.K.; Kumar, A.; Mewara, A.; Bardia, M.R. Allele frequency of ABO blood group antigen and the risk of esophageal cancer. BioMed Res. Int., 2014, 2014286810
[http://dx.doi.org/10.1155/2014/286810] [PMID: 25054136]

Ah-Moye, D.; Davies, C.; Goody, J.; Hayward, P.; Frewin, R. Introduction to Haematology and Transfusion Science. In: Clinical Biochem-istry: Metabolic and Clinical Aspects; Marshall, W.; Lapsley, M.; Day, A.; Ayling, R., Eds.; Elsevier: Amsterdam, Netherlands, 2014, pp. 497-514.
[http://dx.doi.org/10.1016/B978-0-7020-5140-1.00026-2]

Alpoim, P.N.; de Barros Pinheiro, M.; Junqueira, D.R.G.; Freitas, L.G. das Graças Carvalho, M.; Fernandes, A.P.; Komatsuzaki, F.; Gomes, K.B.; Sant’Ana Dusse, L.M. Preeclampsia and ABO blood groups: A systematic review and meta-analysis. Mol. Biol. Rep., 2013, 40(3), 2253-2261.
[http://dx.doi.org/10.1007/s11033-012-2288-2] [PMID: 23184045]

He, M.; Wolpin, B.; Rexrode, K.; Manson, J.E.; Rimm, E.; Hu, F.B.; Qi, L. ABO blood group and risk of coronary heart disease in two pro-spective cohort studies. Arterioscler. Thromb. Vasc. Biol., 2012, 32(9), 2314-2320.
[http://dx.doi.org/10.1161/ATVBAHA.112.248757] [PMID: 22895671]

Miao, S-Y.; Zhou, W.; Chen, L.; Wang, S.; Liu, X-A. Influence of ABO blood group and Rhesus factor on breast cancer risk: A meta-analysis of 9665 breast cancer patients and 244,768 controls. Asia Pac. J. Clin. Oncol., 2014, 10(2), 101-108.
[http://dx.doi.org/10.1111/ajco.12083] [PMID: 23714093]

Li, B.; Tan, B.; Chen, C.; Zhao, L.; Qin, L. Association between the ABO blood group and risk of common cancers. J. Evid. Based Med., 2014, 7(2), 79-83.
[http://dx.doi.org/10.1111/jebm.12098] [PMID: 25155765]

Wang, W.; Liu, L.; Wang, Z.; Lu, X.; Wei, M.; Lin, T.; Zhang, Y.; Jiang, S.; Wang, Q.; Cao, Z.; Shi, M. ABO blood group and esophageal carcinoma risk: from a case-control study in Chinese population to meta-analysis. Cancer Causes Control, 2014, 25(10), 1369-1377.
[http://dx.doi.org/10.1007/s10552-014-0442-y] [PMID: 25064033]

Lindesmith, L.; Moe, C.; Marionneau, S.; Ruvoen, N.; Jiang, X.; Lindblad, L.; Stewart, P.; LePendu, J.; Baric, R. Human susceptibility and resistance to Norwalk virus infection. Nat. Med., 2003, 9(5), 548-553.
[http://dx.doi.org/10.1038/nm860] [PMID: 12692541]

Hutson, A.M.; Atmar, R.L.; Graham, D.Y.; Estes, M.K. Norwalk virus infection and disease is associated with ABO histo-blood group type. J. Infect. Dis., 2002, 185(9), 1335-1337.
[http://dx.doi.org/10.1086/339883] [PMID: 12001052]

Cheng, Y.; Cheng, G.; Chui, C.H.; Lau, F.Y.; Chan, P.K.S.; Ng, M.H.L.; Sung, J.J.Y.; Wong, R.S.M. ABO blood group and susceptibility to severe acute respiratory syndrome. JAMA, 2005, 293(12), 1450-1451.
[PMID: 15784866]

Li, Y.; Liu, L.; Huang, Y.; Zheng, H.; Li, L. Association of ABO polymorphisms and pancreatic Cancer/Cardiocerebrovascular disease: A meta-analysis. BMC Med. Genet., 2020, 21(1), 41.
[http://dx.doi.org/10.1186/s12881-020-0975-8] [PMID: 32093636]

Ellinghaus, D.; Degenhardt, F.; Bujanda, L.; Buti, M.; Albillos, A.; Invernizzi, P.; Fernández, J.; Prati, D.; Baselli, G.; Asselta, R.; Grimsrud, M.M.; Milani, C.; Aziz, F.; Kässens, J.; May, S.; Wendorff, M.; Wienbrandt, L.; Uellendahl-Werth, F.; Zheng, T.; Yi, X.; de Pablo, R.; Cher-coles, A.G.; Palom, A.; Garcia-Fernandez, A.E.; Rodriguez-Frias, F.; Zanella, A.; Bandera, A.; Protti, A.; Aghemo, A.; Lleo, A.; Biondi, A.; Caballero-Garralda, A.; Gori, A.; Tanck, A.; Carreras Nolla, A.; Latiano, A.; Fracanzani, A.L.; Peschuck, A.; Julià, A.; Pesenti, A.; Voza, A.; Jiménez, D.; Mateos, B.; Nafria Jimenez, B.; Quereda, C.; Paccapelo, C.; Gassner, C.; Angelini, C.; Cea, C.; Solier, A.; Pestaña, D.; Muñiz-Diaz, E.; Sandoval, E.; Paraboschi, E.M.; Navas, E.; García Sánchez, F.; Ceriotti, F.; Martinelli-Boneschi, F.; Peyvandi, F.; Blasi, F.; Téllez, L.; Blanco-Grau, A.; Hemmrich-Stanisak, G.; Grasselli, G.; Costantino, G.; Cardamone, G.; Foti, G.; Aneli, S.; Kurihara, H.; ElAbd, H.; My, I.; Galván-Femenia, I.; Martín, J.; Erdmann, J.; Ferrusquía-Acosta, J.; Garcia-Etxebarria, K.; Izquierdo-Sanchez, L.; Bettini, L.R.; Sumoy, L.; Terranova, L.; Moreira, L.; Santoro, L.; Scudeller, L.; Mesonero, F.; Roade, L.; Rühlemann, M.C.; Schaefer, M.; Carrabba, M.; Riveiro-Barciela, M.; Figuera Basso, M.E.; Valsecchi, M.G.; Hernandez-Tejero, M.; Acosta-Herrera, M.; D’Angiò, M.; Baldini, M.; Cazzaniga, M.; Schulzky, M.; Cecconi, M.; Wittig, M.; Ciccarelli, M.; Rodríguez-Gandía, M.; Bocciolone, M.; Miozzo, M.; Montano, N.; Braun, N.; Sacchi, N.; Martínez, N.; Özer, O.; Palmieri, O.; Faverio, P.; Preatoni, P.; Bonfanti, P.; Omodei, P.; Tentorio, P.; Castro, P.; Rodrigues, P.M. Blan-dino Ortiz, A.; de Cid, R.; Ferrer, R.; Gualtierotti, R.; Nieto, R.; Goerg, S.; Badalamenti, S.; Marsal, S.; Matullo, G.; Pelusi, S.; Juzenas, S.; Aliberti, S.; Monzani, V.; Moreno, V.; Wesse, T.; Lenz, T.L.; Pumarola, T.; Rimoldi, V.; Bosari, S.; Albrecht, W.; Peter, W.; Romero-Gómez, M.; D’Amato, M.; Duga, S.; Banales, J.M.; Hov, J.R.; Folseraas, T.; Valenti, L.; Franke, A.; Karlsen, T.H. The Severe Covid-19 GWAS Group. Genomewide association study of severe Covid-19 with respiratory failure. N. Engl. J. Med., 2020, 383(16), 1522-1534.
[http://dx.doi.org/10.1056/NEJMoa2020283] [PMID: 32558485]

Hoiland, R.L.; Fergusson, N.A.; Mitra, A.R.; Griesdale, D.E.G.; Devine, D.V.; Stukas, S.; Cooper, J.; Thiara, S.; Foster, D.; Chen, L.Y.C.; Lee, A.Y.Y.; Conway, E.M.; Wellington, C.L.; Sekhon, M.S. The association of ABO blood group with indices of disease severity and mul-tiorgan dysfunction in COVID-19. Blood Adv., 2020, 4(20), 4981-4989.
[http://dx.doi.org/10.1182/bloodadvances.2020002623] [PMID: 33057633]

Balanovsky, O.; Petrushenko, V.; Mirzaev, K.; Abdullaev, S.; Gorin, I.; Chernevskiy, D.; Agdzhoyan, A.; Balanovska, E.; Alexander, K.; Sychev, D. The variation of genome sites associated with severe COVID-19 across populations: the worldwide and national patterns. medRxiv, 2020.
[http://dx.doi.org/10.1101/2020.11.22.20236414]

Teupser, D.; Baber, R.; Ceglarek, U.; Scholz, M.; Illig, T.; Gieger, C.; Holdt, L.M.; Leichtle, A.; Greiser, K.H.; Huster, D.; Linsel-Nitschke, P.; Schäfer, A.; Braund, P.S.; Tiret, L.; Stark, K.; Raaz-Schrauder, D.; Fiedler, G.M.; Wilfert, W.; Beutner, F.; Gielen, S.; Grosshennig, A.; König, I.R.; Lichtner, P.; Heid, I.M.; Kluttig, A.; El Mokhtari, N.E.; Rubin, D.; Ekici, A.B.; Reis, A.; Garlichs, C.D.; Hall, A.S.; Matthes, G.; Wittekind, C.; Hengstenberg, C.; Cambien, F.; Schreiber, S.; Werdan, K.; Meitinger, T.; Loeffler, M.; Samani, N.J.; Erdmann, J.; Wichmann, H-E.; Schunkert, H.; Thiery, J. Genetic regulation of serum phytosterol levels and risk of coronary artery disease. Circ. Cardiovasc. Genet., 2010, 3(4), 331-339.
[http://dx.doi.org/10.1161/CIRCGENETICS.109.907873] [PMID: 20529992]

Xu, H-L.; Cheng, J-R.; Zhang, W.; Wang, J.; Yu, H.; Ni, Q-X.; Risch, H.A.; Gao, Y-T. Re-evaluation of ABO gene polymorphisms detected in a genome-wide association study and risk of pancreatic ductal adenocarcinoma in a Chinese population. Chin. J. Cancer, 2014, 33(2), 68-73.
[http://dx.doi.org/10.5732/cjc.013.10060] [PMID: 23816557]

Olson, N.C.; Butenas, S.; Lange, L.A.; Lange, E.M.; Cushman, M.; Jenny, N.S.; Walston, J.; Souto, J.C.; Soria, J.M.; Chauhan, G.; Debette, S.; Longstreth, W.T.; Seshadri, S.; Reiner, A.P.; Tracy, R.P. Coagulation factor XII genetic variation, ex vivo thrombin generation, and stroke risk in the elderly: results from the Cardiovascular Health Study. J. Thromb. Haemost., 2015, 13(10), 1867-1877.
[http://dx.doi.org/10.1111/jth.13111] [PMID: 26286125]

Kerbikov, O.; Orekhov, P.; Borskaya, E.; Nosenko, N. High incidence of venous thrombosis in patients with moderate-to-severe COVID-19. Int. J. Hematol., 2021, 113(3), 344-347.
[http://dx.doi.org/10.1007/s12185-020-03061-y] [PMID: 33389655]

Zabaneh, D.; Gaunt, T.R.; Kumari, M.; Drenos, F.; Shah, S.; Berry, D.; Power, C.; Hypponen, E.; Shah, T.; Palmen, J.; Pallas, J.; Talmud, P.J.; Casas, J.P.; Sofat, R.; Lowe, G.; Rumley, A.; Morris, R.W.; Whincup, P.H.; Rodriguez, S.; Ebrahim, S.; Marmot, M.G.; Smith, G.D.; Lawlor, D.A.; Kivimaki, M.; Whittaker, J.; Hingorani, A.D.; Day, I.N.; Humphries, S.E. Genetic variants associated with Von Willebrand factor levels in healthy men and women identified using the HumanCVD BeadChip. Ann. Hum. Genet., 2011, 75(4), 456-467.
[http://dx.doi.org/10.1111/j.1469-1809.2011.00654.x] [PMID: 21534939]

Helms, J.; Tacquard, C.; Severac, F.; Leonard-Lorant, I.; Ohana, M.; Delabranche, X.; Merdji, H.; Clere-Jehl, R.; Schenck, M. Fagot Gan-det, F.; Fafi-Kremer, S.; Castelain, V.; Schneider, F.; Grunebaum, L.; Anglés-Cano, E.; Sattler, L.; Mertes, P.M.; Meziani, F. High risk of thrombosis in patients with severe SARS-CoV-2 infection: A multicenter prospective cohort study. Intensive Care Med., 2020, 46(6), 1089-1098.
[http://dx.doi.org/10.1007/s00134-020-06062-x] [PMID: 32367170]

Goel, R.; Bloch, E.M.; Pirenne, F.; Al-Riyami, A.Z.; Crowe, E.; Dau, L.; Land, K.; Townsend, M.; Jecko, T.; Rahimi-Levene, N.; Patidar, G.; Josephson, C.D.; Arora, S.; Vermeulen, M.; Vrielink, H.; Montemayor, C.; Oreh, A.; Hindawi, S.; van den Berg, K.; Serrano, K.; So-Osman, C.; Wood, E.; Devine, D.V.; Spitalnik, S.L. ABO blood group and COVID-19: A review on behalf of the ISBT COVID-19 Working Group. Vox Sang., 2021, 116(8), 849-861.
[http://dx.doi.org/10.1111/vox.13076] [PMID: 33578447]

Streetley, J.; Fonseca, A-V.; Turner, J.; Kiskin, N.I.; Knipe, L.; Rosenthal, P.B.; Carter, T. Stimulated release of intraluminal vesicles from Weibel-Palade bodies. Blood, 2019, 133(25), 2707-2717.
[http://dx.doi.org/10.1182/blood-2018-09-874552] [PMID: 30760452]

Delbrück, C.; Miesbach, W. The course of von Willebrand factor and factor VIII activity in patients with von Willebrand disease during pregnancy. Acta Haematol., 2019, 142(2), 71-78.
[http://dx.doi.org/10.1159/000496820] [PMID: 31085919]

Aksenova, A.Y. Von Willebrand factor and endothelial damage: A possible association with COVID-19. Ekol. Genet., 2020, 18(2), 135-138.
[http://dx.doi.org/10.17816/ecogen33973]

Iba, T.; Connors, J.M.; Levy, J.H. The coagulopathy, endotheliopathy, and vasculitis of COVID-19. Inflamm. Res., 2020, 69(12), 1181-1189.
[http://dx.doi.org/10.1007/s00011-020-01401-6] [PMID: 32918567]

Sweeney, J.M.; Barouqa, M.; Krause, G.J.; Gonzalez-Lugo, J.D.; Rahman, S.; Gil, M.R. Evidence for secondary thrombotic microangiopa-thy in COVID-19. medRxiv, 2020.
[http://dx.doi.org/10.1101/2020.10.20.20215608]

Lopez-Castaneda, S.; García-Larragoiti, N.; Cano-Mendez, A.; Blancas-Ayala, K.; Damian-Vázquez, G.; Perez-Medina, A.I.; Chora-Hernández, L.D.; Arean-Martínez, C.; Viveros-Sandoval, M.E. Inflammatory and prothrombotic biomarkers associated with the severity of COVID-19 infection. Clin. Appl. Thromb. Hemost., 2021, 271076029621999099
[http://dx.doi.org/10.1177/1076029621999099] [PMID: 33835872]

Mei, Z.W.; van Wijk, X.M.R.; Pham, H.P.; Marin, M.J. Role of von Willebrand factor in COVID-19 associated coagulopathy. J. Appl. Lab. Med., 2021, 6(5), 1305-1315.
[http://dx.doi.org/10.1093/jalm/jfab042] [PMID: 33930144]

Rauch, A.; Labreuche, J.; Lassalle, F.; Goutay, J.; Caplan, M.; Charbonnier, L.; Rohn, A.; Jeanpierre, E.; Dupont, A.; Duhamel, A.; Faure, K.; Lambert, M.; Kipnis, E.; Garrigue, D.; Lenting, P.J.; Poissy, J.; Susen, S. Coagulation biomarkers are independent predictors of in-creased oxygen requirements in COVID-19. J. Thromb. Haemost., 2020, 18(11), 2942-2953.
[http://dx.doi.org/10.1111/jth.15067] [PMID: 32881304]

Ladikou, E.E.; Sivaloganathan, H.; Milne, K.M.; Arter, W.E.; Ramasamy, R.; Saad, R.; Stoneham, S.M.; Philips, B.; Eziefula, A.C.; Che-vassut, T. Von Willebrand factor (vWF): marker of endothelial damage and thrombotic risk in COVID-19? Clin. Med. (Lond.), 2020, 20(5), e178-e182.
[http://dx.doi.org/10.7861/clinmed.2020-0346] [PMID: 32694169]

Pottinger, B.E.; Read, R.C.; Paleolog, E.M.; Higgins, P.G.; Pearson, J.D. von Willebrand factor is an acute phase reactant in man. Thromb. Res., 1989, 53(4), 387-394.
[http://dx.doi.org/10.1016/0049-3848(89)90317-4] [PMID: 2467404]

Jiang, S.; Sun, L. Tongue Sole CD209: A pattern-recognition receptor that binds a broad range of microbes and promotes phagocytosis. Int. J. Mol. Sci., 2017, 18(9), 1848.
[http://dx.doi.org/10.3390/ijms18091848] [PMID: 28869534]

Wang, L.; Balmat, T.J.; Antonia, A.L.; Constantine, F.J.; Henao, R.; Burke, T.W.; Ingham, A.; McClain, M.T.; Tsalik, E.L.; Ko, E.R.; Gins-burg, G.S.; DeLong, M.R.; Shen, X.; Woods, C.W.; Hauser, E.R.; Ko, D.C. An atlas connecting shared genetic architecture of human diseas-es and molecular phenotypes provides insight into COVID-19 susceptibility. medRxiv, 2020.
[http://dx.doi.org/10.1101/2020.12.20.20248572]

Jeffers, S.A.; Tusell, S.M.; Gillim-Ross, L.; Hemmila, E.M.; Achenbach, J.E.; Babcock, G.J.; Thomas, W.D., Jr; Thackray, L.B.; Young, M.D.; Mason, R.J.; Ambrosino, D.M.; Wentworth, D.E.; Demartini, J.C.; Holmes, K.V. CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus. Proc. Natl. Acad. Sci. USA, 2004, 101(44), 15748-15753.
[http://dx.doi.org/10.1073/pnas.0403812101] [PMID: 15496474]

Rahimi, N. C-type lectin CD209L/L-SIGN and CD209/DC-SIGN: cell adhesion molecules turned to pathogen recognition receptors. Biology (Basel), 2020, 10(1), 1.
[http://dx.doi.org/10.3390/biology10010001] [PMID: 33375175]

Amraie, R.; Napoleon, M.A.; Yin, W.; Berrigan, J.; Suder, E.; Zhao, G.; Olejnik, J.; Gummuluru, S.; Muhlberger, E.; Chitalia, V.; Rahimi, N. CD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2 and are differentially expressed in lung and kidney epithelial and endothelial cells. bioRxiv, 2020.
[http://dx.doi.org/10.1101/2020.06.22.165803]

Hamming, I.; Timens, W.; Bulthuis, M.L.C.; Lely, A.T.; Navis, G.; van Goor, H. Tissue distribution of ACE2 protein, the functional recep-tor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol., 2004, 203(2), 631-637.
[http://dx.doi.org/10.1002/path.1570] [PMID: 15141377]

Li, M-Y.; Li, L.; Zhang, Y.; Wang, X-S. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect. Dis. Poverty, 2020, 9(1), 45.
[http://dx.doi.org/10.1186/s40249-020-00662-x] [PMID: 32345362]

Ganier, C.; Du-Harpur, X.; Harun, N.; Wan, B.; Arthurs, C.; Luscombe, N.M.; Watt, F.M.; Lynch, M.D. CD147 (BSG) but not ACE2 ex-pression is detectable in vascular endothelial cells within single cell RNA sequencing datasets derived from multiple tissues in healthy indi-viduals. bioRxiv, 2020.
[http://dx.doi.org/10.1101/2020.05.29.123513]

Hikmet, F.; Méar, L.; Edvinsson, Å.; Micke, P.; Uhlén, M.; Lindskog, C. The protein expression profile of ACE2 in human tissues. Mol. Syst. Biol., 2020, 16(7)e9610
[http://dx.doi.org/10.15252/msb.20209610] [PMID: 32715618]

Kim, Y-C.; Jeong, B-H. Strong correlation between the case fatality rate of COVID-19 and the rs6598045 single nucleotide polymorphism (SNP) of the interferon-induced transmembrane protein 3 (IFITM3) gene at the population-level. Genes (Basel), 2020, 12(1), 42.
[http://dx.doi.org/10.3390/genes12010042] [PMID: 33396837]

Lehrer, S.; Rheinstein, P.H. ABO blood groups, COVID-19 infection and mortality. Blood Cells Mol. Dis., 2021, 89102571
[http://dx.doi.org/10.1016/j.bcmd.2021.102571] [PMID: 33894687]

Groot, H.E.; Villegas Sierra, L.E.; Said, M.A.; Lipsic, E.; Karper, J.C.; van der Harst, P. Genetically determined ABO blood group and its associations with health and disease. Arterioscler. Thromb. Vasc. Biol., 2020, 40(3), 830-838.
[http://dx.doi.org/10.1161/ATVBAHA.119.313658] [PMID: 31969017]

Gómez, J.; Albaiceta, G.M.; García-Clemente, M.; García-Gala, J.M.; Coto, E. DNA genotyping of the ABO gene showed a significant asso-ciation of the A-group (A1/A2 variants) with severe COVID-19. Eur. J. Intern. Med., 2021, 88, 129-132.
[http://dx.doi.org/10.1016/j.ejim.2021.02.016] [PMID: 33750629]

Shelton, J.F.; Shastri, A.J.; Ye, C.; Weldon, C.H.; Filshtein-Sonmez, T.; Coker, D.; Symons, A.; Esparza-Gordillo, J.; Aslibekyan, S.; Auton, A. Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity. Nat. Genet., 2021, 53(6), 801-808.
[http://dx.doi.org/10.1038/s41588-021-00854-7] [PMID: 33888907]

Nakao, M.; Matsuo, K.; Ito, H.; Shitara, K.; Hosono, S.; Watanabe, M.; Ito, S.; Sawaki, A.; Iida, S.; Sato, S.; Yatabe, Y.; Yamao, K.; Ueda, R.; Tajima, K.; Hamajima, N.; Tanaka, H. ABO genotype and the risk of gastric cancer, atrophic gastritis, and Helicobacter pylori infection. Cancer Epidemiol. Biomarkers Prev., 2011, 20(8), 1665-1672.
[http://dx.doi.org/10.1158/1055-9965.EPI-11-0213] [PMID: 21680535]

Greer, J.B.; LaRusch, J.; Brand, R.E.; O’Connell, M.R.; Yadav, D.; Whitcomb, D.C. ABO blood group and chronic pancreatitis risk in the NAPS2 cohort. Pancreas, 2011, 40(8), 1188-1194.
[http://dx.doi.org/10.1097/MPA.0b013e3182232975] [PMID: 21792085]

Centers for Disease Control and Prevention. People with Certain Medical Conditions. Available from: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2F coronavirus%2F2019-ncov%2Fneed-extra-precautions%2Fgroupsat- higher-risk.html#print (Accessed May 6, 2021).

Chung, C-M.; Wang, R-Y.; Chen, J-W.; Fann, C.S.J.; Leu, H-B.; Ho, H-Y.; Ting, C-T.; Lin, T-H.; Sheu, S-H.; Tsai, W-C.; Chen, J-H.; Jong, Y-S.; Lin, S-J.; Chen, Y-T.; Pan, W-H. A genome-wide association study identifies new loci for ACE activity: potential implications for re-sponse to ACE inhibitor. Pharmacogenomics J., 2010, 10(6), 537-544.
[http://dx.doi.org/10.1038/tpj.2009.70] [PMID: 20066004]

Keidar, S.; Kaplan, M.; Gamliel-Lazarovich, A. ACE2 of the heart: From angiotensin I to angiotensin (1-7). Cardiovasc. Res., 2007, 73(3), 463-469.
[http://dx.doi.org/10.1016/j.cardiores.2006.09.006] [PMID: 17049503]

Dai, X. ABO blood group predisposes to COVID-19 severity and cardiovascular diseases. Eur. J. Prev. Cardiol., 2020, 27(13), 1436-1437.
[http://dx.doi.org/10.1177/2047487320922370] [PMID: 32343152]

Tukiainen, T.; Villani, A.C.; Yen, A.; Rivas, M.A.; Marshall, J.L.; Satija, R.; Aguirre, M.; Gauthier, L.; Fleharty, M.; Kirby, A.; Cummings, B.B.; Castel, S.E.; Karczewski, K.J.; Aguet, F.; Byrnes, A.; Lappalainen, T.; Regev, A.; Ardlie, K.G.; Hacohen, N.; MacArthur, D.G. Land-scape of X chromosome inactivation across human tissues. Nature, 2017, 550(7675), 244-248.
[http://dx.doi.org/10.1038/nature24265] [PMID: 29022598]

Gagliardi, M.C.; Tieri, P.; Ortona, E.; Ruggieri, A. ACE2 expression and sex disparity in COVID-19. Cell Death Discov., 2020, 6(1), 37.
[http://dx.doi.org/10.1038/s41420-020-0276-1] [PMID: 32499922]

Foresta, C.; Rocca, M.S.; Di Nisio, A. Gender susceptibility to COVID-19: A review of the putative role of sex hormones and X chromo-some. J. Endocrinol. Invest., 2021, 44(5), 951-956.
[http://dx.doi.org/10.1007/s40618-020-01383-6] [PMID: 32936429]

Bukowska, A.; Spiller, L.; Wolke, C.; Lendeckel, U.; Weinert, S.; Hoffmann, J.; Bornfleth, P.; Kutschka, I.; Gardemann, A.; Isermann, B.; Goette, A. Protective regulation of the ACE2/ACE gene expression by estrogen in human atrial tissue from elderly men. Exp. Biol. Med. (Maywood), 2017, 242(14), 1412-1423.
[http://dx.doi.org/10.1177/1535370217718808] [PMID: 28661206]

Acheampong, D.O.; Barffour, I.K.; Boye, A.; Aninagyei, E.; Ocansey, S.; Morna, M.T. Male predisposition to severe COVID-19: Review of evidence and potential therapeutic prospects. Biomed. Pharmacother., 2020, 131110748
[http://dx.doi.org/10.1016/j.biopha.2020.110748] [PMID: 33152916]

Tavares, C.A.M.; Avelino-Silva, T.J.; Benard, G.; Cardozo, F.A.M.; Fernandes, J.R.; Girardi, A.C.C.; Jacob Filho, W. ACE2 expression and risk factors for COVID-19 severity in patients with advanced age. Arq. Bras. Cardiol., 2020, 115(4), 701-707.
[http://dx.doi.org/10.36660/abc.20200487] [PMID: 33111872]

Chen, J.; Jiang, Q.; Xia, X.; Liu, K.; Yu, Z.; Tao, W.; Gong, W.; Han, J.J. Individual variation of the SARS-CoV-2 receptor ACE2 gene ex-pression and regulation. Aging Cell, 2020, 19(7)e13168
[http://dx.doi.org/10.1111/acel.13168] [PMID: 32558150]

Santos, R.A.S.; Sampaio, W.O.; Alzamora, A.C.; Motta-Santos, D.; Alenina, N.; Bader, M.; Campagnole-Santos, M.J. The ACE2/angiotensin-(1–7)/MAS axis of the renin-angiotensin system: focus on angiotensin-(1–7). Physiol. Rev., 2018, 98(1), 505-553.
[http://dx.doi.org/10.1152/physrev.00023.2016] [PMID: 29351514]

Kuba, K.; Imai, Y.; Penninger, J.M. Angiotensin-converting enzyme 2 in lung diseases. Curr. Opin. Pharmacol., 2006, 6(3), 271-276.
[http://dx.doi.org/10.1016/j.coph.2006.03.001] [PMID: 16581295]

Imai, Y.; Kuba, K.; Ohto-Nakanishi, T.; Penninger, J.M. Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis. Circ. J., 2010, 74(3), 405-410.
[http://dx.doi.org/10.1253/circj.CJ-10-0045] [PMID: 20134095]

Ni, W.; Yang, X.; Yang, D.; Bao, J.; Li, R.; Xiao, Y.; Hou, C.; Wang, H.; Liu, J.; Yang, D.; Xu, Y.; Cao, Z.; Gao, Z. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit. Care, 2020, 24(1), 422.
[http://dx.doi.org/10.1186/s13054-020-03120-0] [PMID: 32660650]

Gkogkou, E.; Barnasas, G.; Vougas, K.; Trougakos, I.P. Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of putative modulators. Redox Biol., 2020, 36101615
[http://dx.doi.org/10.1016/j.redox.2020.101615] [PMID: 32863223]

Shang, J.; Wan, Y.; Luo, C.; Ye, G.; Geng, Q.; Auerbach, A.; Li, F. Cell entry mechanisms of SARS-CoV-2. Proc. Natl. Acad. Sci. USA, 2020, 117(21), 11727-11734.
[http://dx.doi.org/10.1073/pnas.2003138117] [PMID: 32376634]

Wooster, L.; Nicholson, C.J.; Sigurslid, H.H.; Lino Cardenas, C.L.; Malhotra, R. Polymorphisms in the ACE2 locus associate with severity of COVID-19 infection. bioRxiv, 2020.
[http://dx.doi.org/10.1101/2020.06.18.20135152]

Srivastava, A.; Bandopadhyay, A.; Das, D.; Pandey, R.K.; Singh, V.; Khanam, N.; Srivastava, N.; Singh, P.P.; Dubey, P.K.; Pathak, A.; Gupta, P.; Rai, N.; Sultana, G.N.N.; Chaubey, G. Genetic association of ACE2 rs2285666 polymorphism with COVID-19 spatial distribu-tion in India. Front. Genet., 2020, 11564741
[http://dx.doi.org/10.3389/fgene.2020.564741] [PMID: 33101387]

Patnaik, M.; Pati, P.; Swain, S.N.; Mohapatra, M.K.; Dwibedi, B.; Kar, S.K.; Ranjit, M. Association of angiotensin-converting enzyme and angiotensin-converting enzyme-2 gene polymorphisms with essential hypertension in the population of Odisha, India. Ann. Hum. Biol., 2014, 41(2), 145-152.
[http://dx.doi.org/10.3109/03014460.2013.837195] [PMID: 24112034]

Pan, Y.; Wang, T.; Li, Y.; Guan, T.; Lai, Y.; Shen, Y.; Zeyaweiding, A.; Maimaiti, T.; Li, F.; Zhao, H.; Liu, C. Association of ACE2 poly-morphisms with susceptibility to essential hypertension and dyslipidemia in Xinjiang, China. Lipids Health Dis., 2018, 17(1), 241.
[http://dx.doi.org/10.1186/s12944-018-0890-6] [PMID: 30342552]

Fan, Z.; Wu, G.; Yue, M.; Ye, J.; Chen, Y.; Xu, B.; Shu, Z.; Zhu, J.; Lu, N.; Tan, X. Hypertension and hypertensive left ventricular hyper-trophy are associated with ACE2 genetic polymorphism. Life Sci., 2019, 225, 39-45.
[http://dx.doi.org/10.1016/j.lfs.2019.03.059] [PMID: 30917908]

Luo, Y.; Liu, C.; Guan, T.; Li, Y.; Lai, Y.; Li, F.; Zhao, H.; Maimaiti, T.; Zeyaweiding, A. Association of ACE2 genetic polymorphisms with hypertension-related target organ damages in south Xinjiang. Hypertens. Res., 2019, 42(5), 681-689.
[http://dx.doi.org/10.1038/s41440-018-0166-6] [PMID: 30542083]

Patel, S.K.; Wai, B.; Ord, M.; MacIsaac, R.J.; Grant, S.; Velkoska, E.; Panagiotopoulos, S.; Jerums, G.; Srivastava, P.M.; Burrell, L.M. As-sociation of ACE2 genetic variants with blood pressure, left ventricular mass, and cardiac function in Caucasians with type 2 diabetes. Am. J. Hypertens., 2012, 25(2), 216-222.
[http://dx.doi.org/10.1038/ajh.2011.188] [PMID: 21993363]

Lieb, W.; Graf, J.; Götz, A.; König, I.R.; Mayer, B.; Fischer, M.; Stritzke, J.; Hengstenberg, C.; Holmer, S.R.; Döring, A.; Löwel, H.; Schunkert, H.; Erdmann, J. Association of angiotensin-converting enzyme 2 (ACE2) gene polymorphisms with parameters of left ventricu-lar hypertrophy in men. Results of the MONICA Augsburg echocardiographic substudy. J. Mol. Med. (Berl.), 2006, 84(1), 88-96.
[http://dx.doi.org/10.1007/s00109-005-0718-5] [PMID: 16283142]

Liu, C.; Li, Y.; Guan, T.; Lai, Y.; Shen, Y.; Zeyaweiding, A.; Zhao, H.; Li, F.; Maimaiti, T. ACE2 polymorphisms associated with cardio-vascular risk in Uygurs with type 2 diabetes mellitus. Cardiovasc. Diabetol., 2018, 17(1), 127.
[http://dx.doi.org/10.1186/s12933-018-0771-3] [PMID: 30227878]

Zheng, Y-Y.; Ma, Y-T.; Zhang, J-Y.; Xie, X. COVID-19 and the cardiovascular system. Nat. Rev. Cardiol., 2020, 17(5), 259-260.
[http://dx.doi.org/10.1038/s41569-020-0360-5] [PMID: 32139904]

Fang, L.; Karakiulakis, G.; Roth, M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir. Med., 2020, 8(4)e21
[http://dx.doi.org/10.1016/S2213-2600(20)30116-8] [PMID: 32171062]

Mukherjee, S.; Pahan, K. Is COVID-19 Gender-sensitive? J. Neuroimmune Pharmacol., 2021, 16(1), 38-47.
[http://dx.doi.org/10.1007/s11481-020-09974-z] [PMID: 33405098]

Hamet, P.; Pausova, Z.; Attaoua, R.; Hishmih, C.; Haloui, M.; Shin, J.; Paus, T.; Abrahamowicz, M.; Gaudet, D.; Santucci, L.; Kotchen, T.A.; Cowley, A.W.; Hussin, J.; Tremblay, J. SARS-CoV-2 receptor ACE2 gene is associated with hypertension and severity of COVID 19: interaction with sex, obesity, and smoking. Am. J. Hypertens., 2021, 34(4), 367-376.
[http://dx.doi.org/10.1093/ajh/hpaa223] [PMID: 33386398]

Zhong, J.; Yan, Z.; Liu, D.; Ni, Y.; Zhao, Z.; Zhu, S.; Tepel, M.; Zhu, Z. Association of angiotensin-converting enzyme 2 gene A/G poly-morphism and elevated blood pressure in Chinese patients with metabolic syndrome. J. Lab. Clin. Med., 2006, 147(2), 91-95.
[http://dx.doi.org/10.1016/j.lab.2005.10.001] [PMID: 16459167]

Zhang, Q.; Cong, M.; Wang, N.; Li, X.; Zhang, H.; Zhang, K.; Jin, M.; Wu, N.; Qiu, C.; Li, J. Association of angiotensin-converting enzyme 2 gene polymorphism and enzymatic activity with essential hypertension in different gender: A case-control study. Medicine (Baltimore), 2018, 97(42)e12917
[http://dx.doi.org/10.1097/MD.0000000000012917] [PMID: 30335025]

Vangjeli, C.; Dicker, P.; Tregouet, D-A.; Shields, D.C.; Evans, A.; Stanton, A.V. A polymorphism in ACE2 is associated with a lower risk for fatal cardiovascular events in females: the MORGAM project. J. Renin Angiotensin Aldosterone Syst., 2011, 12(4), 504-509.
[http://dx.doi.org/10.1177/1470320311405557] [PMID: 21490025]

Yang, W.; Huang, W.; Su, S.; Li, B.; Zhao, W.; Chen, S.; Gu, D. Association study of ACE2 (angiotensin I-converting enzyme 2) gene pol-ymorphisms with coronary heart disease and myocardial infarction in a Chinese Han population. Clin. Sci. (Lond.), 2006, 111(5), 333-340.
[http://dx.doi.org/10.1042/CS20060020] [PMID: 16822235]

Novelli, A.; Biancolella, M.; Borgiani, P.; Cocciadiferro, D.; Colona, V.L.; D’Apice, M.R.; Rogliani, P.; Zaffina, S.; Leonardis, F.; Campana, A.; Raponi, M.; Andreoni, M.; Grelli, S.; Novelli, G. Analysis of ACE2 genetic variants in 131 Italian SARS-CoV-2-positive patients. Hum. Genomics, 2020, 14(1), 29.
[http://dx.doi.org/10.1186/s40246-020-00279-z] [PMID: 32917283]

Karakaş Çelik, S.; Çakmak Genç, G.; Pişkin, N.; Açikgöz, B.; Altinsoy, B.; Kurucu İşsiz, B.; Dursun, A. Polymorphisms of ACE (I/D) and ACE2 receptor gene (Rs2106809, Rs2285666) are not related to the clinical course of COVID-19: A case study. J. Med. Virol., 2021, 93(10), 5947-5952.
[http://dx.doi.org/10.1002/jmv.27160] [PMID: 34170561]

Gómez, J.; Albaiceta, G.M.; García-Clemente, M.; López-Larrea, C.; Amado-Rodríguez, L.; Lopez-Alonso, I.; Hermida, T.; Enriquez, A.I.; Herrero, P.; Melón, S.; Alvarez-Argüelles, M.E.; Boga, J.A.; Rojo-Alba, S.; Cuesta-Llavona, E.; Alvarez, V.; Lorca, R.; Coto, E. Angioten-sin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome. Gene, 2020, 762145102
[http://dx.doi.org/10.1016/j.gene.2020.145102] [PMID: 32882331]

Asselta, R.; Paraboschi, E.M.; Mantovani, A.; Duga, S. ACE2 and TMPRSS2 variants and expression as candidates to sex and country dif-ferences in COVID-19 severity in Italy. Aging (Albany NY), 2020, 12(11), 10087-10098.
[http://dx.doi.org/10.18632/aging.103415] [PMID: 32501810]

Chaudhry, F.; Lavandero, S.; Xie, X.; Sabharwal, B.; Zheng, Y-Y.; Correa, A.; Narula, J.; Levy, P. Manipulation of ACE2 expression in COVID-19. Open Heart, 2020, 7(2)e001424
[http://dx.doi.org/10.1136/openhrt-2020-001424] [PMID: 33443121]

Chen, Y.Y.; Zhang, P.; Zhou, X.M.; Liu, D.; Zhong, J.C.; Zhang, C.J.; Jin, L.J.; Yu, H.M. Relationship between genetic variants of ACE2 gene and circulating levels of ACE2 and its metabolites. J. Clin. Pharm. Ther., 2018, 43(2), 189-195.
[http://dx.doi.org/10.1111/jcpt.12625] [PMID: 28895159]

Lin, B.; Ferguson, C.; White, J.T.; Wang, S.; Vessella, R.; True, L.D.; Hood, L.; Nelson, P.S. Prostate-localized and androgen-regulated ex-pression of the membrane-bound serine protease TMPRSS2. Cancer Res., 1999, 59(17), 4180-4184.
[PMID: 10485450]

Shen, L.W.; Mao, H.J.; Wu, Y.L.; Tanaka, Y.; Zhang, W. TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections. Biochimie, 2017, 142, 1-10.
[http://dx.doi.org/10.1016/j.biochi.2017.07.016] [PMID: 28778717]

Baughn, L.B.; Sharma, N.; Elhaik, E.; Sekulic, A.; Bryce, A.H.; Fonseca, R. Targeting TMPRSS2 in SARS-CoV-2 infection. Mayo Clin. Proc., 2020, 95(9), 1989-1999.
[http://dx.doi.org/10.1016/j.mayocp.2020.06.018] [PMID: 32861340]

Wang, S.; Zhou, X.; Zhang, T.; Wang, Z. The need for urogenital tract monitoring in COVID-19. Nat. Rev. Urol., 2020, 17(6), 314-315.
[http://dx.doi.org/10.1038/s41585-020-0319-7] [PMID: 32313110]

Bertram, S.; Heurich, A.; Lavender, H.; Gierer, S.; Danisch, S.; Perin, P.; Lucas, J.M.; Nelson, P.S.; Pöhlmann, S.; Soilleux, E.J. Influenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts. PLoS One, 2012, 7(4)e35876
[http://dx.doi.org/10.1371/journal.pone.0035876] [PMID: 22558251]

Collin, J.; Queen, R.; Zerti, D.; Dorgau, B.; Georgiou, M.; Djidrovski, I.; Hussain, R.; Coxhead, J.M.; Joseph, A.; Rooney, P.; Lisgo, S.; Figueiredo, F.; Armstrong, L.; Lako, M. Co-expression of SARS-CoV-2 entry genes in the superficial adult human conjunctival, limbal and corneal epithelium suggests an additional route of entry via the ocular surface. Ocul. Surf., 2021, 19, 190-200.
[http://dx.doi.org/10.1016/j.jtos.2020.05.013] [PMID: 32502616]

Ziegler, C.G.K.; Allon, S.J.; Nyquist, S.K.; Mbano, I.M.; Miao, V.N.; Tzouanas, C.N.; Cao, Y.; Yousif, A.S.; Bals, J.; Hauser, B.M.; Feld-man, J.; Muus, C.; Wadsworth, M.H., II; Kazer, S.W.; Hughes, T.K.; Doran, B.; Gatter, G.J.; Vukovic, M.; Taliaferro, F.; Mead, B.E.; Guo, Z.; Wang, J.P.; Gras, D.; Plaisant, M.; Ansari, M.; Angelidis, I.; Adler, H.; Sucre, J.M.S.; Taylor, C.J.; Lin, B.; Waghray, A.; Mitsialis, V.; Dwyer, D.F.; Buchheit, K.M.; Boyce, J.A.; Barrett, N.A.; Laidlaw, T.M.; Carroll, S.L.; Colonna, L.; Tkachev, V.; Peterson, C.W.; Yu, A.; Zheng, H.B.; Gideon, H.P.; Winchell, C.G.; Lin, P.L.; Bingle, C.D.; Snapper, S.B.; Kropski, J.A.; Theis, F.J.; Schiller, H.B.; Zaragosi, L-E.; Barbry, P.; Leslie, A.; Kiem, H-P.; Flynn, J.L.; Fortune, S.M.; Berger, B.; Finberg, R.W.; Kean, L.S.; Garber, M.; Schmidt, A.G.; Lingwood, D.; Shalek, A.K.; Ordovas-Montanes, J. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell, 2020, 181(5), 1016-1035.e19.
[http://dx.doi.org/10.1016/j.cell.2020.04.035] [PMID: 32413319]

Russo, R.; Andolfo, I.; Lasorsa, V.A.; Iolascon, A.; Capasso, M. Genetic analysis of the coronavirus SARS-CoV-2 host protease TMPRSS2 in different populations. Front. Genet., 2020, 11, 872.
[http://dx.doi.org/10.3389/fgene.2020.00872] [PMID: 32849840]

Hoffmann, M.; Kleine-Weber, H.; Schroeder, S.; Krüger, N.; Herrler, T.; Erichsen, S.; Schiergens, T.S.; Herrler, G.; Wu, N-H.; Nitsche, A.; Müller, M.A.; Drosten, C.; Pöhlmann, S. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell, 2020, 181(2), 271-280.e8.
[http://dx.doi.org/10.1016/j.cell.2020.02.052] [PMID: 32142651]

Lan, J.; Ge, J.; Yu, J.; Shan, S.; Zhou, H.; Fan, S.; Zhang, Q.; Shi, X.; Wang, Q.; Zhang, L.; Wang, X. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature, 2020, 581(7807), 215-220.
[http://dx.doi.org/10.1038/s41586-020-2180-5] [PMID: 32225176]

Matsuyama, S.; Nao, N.; Shirato, K.; Kawase, M.; Saito, S.; Takayama, I.; Nagata, N.; Sekizuka, T.; Katoh, H.; Kato, F.; Sakata, M.; Tahara, M.; Kutsuna, S.; Ohmagari, N.; Kuroda, M.; Suzuki, T.; Kageyama, T.; Takeda, M. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells. Proc. Natl. Acad. Sci. USA, 2020, 117(13), 7001-7003.
[http://dx.doi.org/10.1073/pnas.2002589117] [PMID: 32165541]

Brest, P.; Refae, S.; Mograbi, B.; Hofman, P.; Milano, G. Host polymorphisms may impact SARS-CoV-2 infectivity. Trends Genet., 2020, 36(11), 813-815.
[http://dx.doi.org/10.1016/j.tig.2020.08.003] [PMID: 32828550]

Zipeto, D.; Palmeira, J.D.F.; Argañaraz, G.A.; Argañaraz, E.R. ACE2/ADAM17/TMPRSS2 interplay may be the main risk factor for COVID-19. Front. Immunol., 2020, 11576745
[http://dx.doi.org/10.3389/fimmu.2020.576745] [PMID: 33117379]

Heurich, A.; Hofmann-Winkler, H.; Gierer, S.; Liepold, T.; Jahn, O.; Pöhlmann, S. TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. J. Virol., 2014, 88(2), 1293-1307.
[http://dx.doi.org/10.1128/JVI.02202-13] [PMID: 24227843]

Andolfo, I.; Russo, R.; Lasorsa, V.A.; Cantalupo, S.; Rosato, B.E.; Bonfiglio, F.; Frisso, G.; Abete, P.; Cassese, G.M.; Servillo, G.; Esposi-to, G.; Gentile, I.; Piscopo, C.; Villani, R.; Fiorentino, G.; Cerino, P.; Buonerba, C.; Pierri, B.; Zollo, M.; Iolascon, A.; Capasso, M. Common variants at 21q22.3 locus influence MX1 and TMPRSS2 gene expression and susceptibility to severe COVID-19. iScience, 2021, 24(4)102322
[http://dx.doi.org/10.1016/j.isci.2021.102322] [PMID: 33748697]

Britto, C.J.; Niu, N.; Khanal, S.; Huleihel, L.; Herazo-Maya, J.D.; Thompson, A.; Sauler, M.; Slade, M.D.; Sharma, L.; Dela Cruz, C.S.; Ka-minski, N.; Cohn, L.E. BPIFA1 regulates lung neutrophil recruitment and interferon signaling during acute inflammation. Am. J. Physiol. Lung Cell. Mol. Physiol., 2019, 316(2), L321-L333.
[http://dx.doi.org/10.1152/ajplung.00056.2018] [PMID: 30461288]

Bizzotto, J.; Sanchis, P.; Abbate, M.; Lage-Vickers, S.; Lavignolle, R.; Toro, A.; Olszevicki, S.; Sabater, A.; Cascardo, F.; Vazquez, E.; Cotignola, J.; Gueron, G. SARS-CoV-2 infection boosts MX1 antiviral effector in COVID-19 patients. iScience, 2020, 23(10)101585
[http://dx.doi.org/10.1016/j.isci.2020.101585] [PMID: 32989429]

David, A.; Parkinson, N.; Peacock, T.P.; Pairo-Castineira, E.; Khanna, T.; Cobat, A.; Tenesa, A.; Sancho-Shimizu, V.; Casanova, J-L.; Abel, L.; Barclay, W.S.; Baillie, J.K.; Sternberg, M.J.E. A common TMPRSS2 variant protects against severe COVID-19. medRxiv, 2021.
[http://dx.doi.org/10.1101/2021.03.04.21252931]

Sharma, S.; Singh, I.; Haider, S.; Malik, M.Z.; Ponnusamy, K.; Rai, E. ACE2 homo-dimerization, human genomic variants and interaction of host proteins explain high population specific differences in outcomes of COVID19. bioRxiv, 2020.
[http://dx.doi.org/10.1101/2020.04.24.050534]

Wulandari, L.; Hamidah, B.; Pakpahan, C.; Damayanti, N.S.; Kurniati, N.D.; Adiatmaja, C.O.; Wigianita, M.R.; Soedarsono, S.; Husada, D.; Tinduh, D.; Prakoeswa, C.R.S.; Endaryanto, A.; Puspaningsih, N.N.T.; Lusida, M.I.; Shimizu, K.; Oceandy, D. Initial study on TMPRSS2 p.Val160Met genetic variant in COVID-19 patients. Research Square, 2021.

Singh, H.; Choudhari, R.; Nema, V.; Khan, A.A. ACE2 and TMPRSS2 polymorphisms in various diseases with special reference to its im-pact on COVID-19 disease. Microb. Pathog., 2021, 150104621
[http://dx.doi.org/10.1016/j.micpath.2020.104621] [PMID: 33278516]

Clinckemalie, L.; Spans, L.; Dubois, V.; Laurent, M.; Helsen, C.; Joniau, S.; Claessens, F. Androgen regulation of the TMPRSS2 gene and the effect of a SNP in an androgen response element. Mol. Endocrinol., 2013, 27(12), 2028-2040.
[http://dx.doi.org/10.1210/me.2013-1098] [PMID: 24109594]

Cheng, Z.; Zhou, J.; To, K.K-W.; Chu, H.; Li, C.; Wang, D.; Yang, D.; Zheng, S.; Hao, K.; Bossé, Y.; Obeidat, M.; Brandsma, C-A.; Song, Y-Q.; Chen, Y.; Zheng, B-J.; Li, L.; Yuen, K-Y. Identification of TMPRSS2 as a susceptibility gene for severe 2009 pandemic A(H1N1) In-fluenza and A(H7N9) influenza. J. Infect. Dis., 2015, 212(8), 1214-1221.
[http://dx.doi.org/10.1093/infdis/jiv246] [PMID: 25904605]

Clohisey, S.; Baillie, J.K. Host susceptibility to severe influenza A virus infection. Crit. Care, 2019, 23(1), 303.
[http://dx.doi.org/10.1186/s13054-019-2566-7] [PMID: 31488196]

Birra, D.; Benucci, M.; Landolfi, L.; Merchionda, A.; Loi, G.; Amato, P.; Licata, G.; Quartuccio, L.; Triggiani, M.; Moscato, P. COVID 19: A clue from innate immunity. Immunol. Res., 2020, 68(3), 161-168.
[http://dx.doi.org/10.1007/s12026-020-09137-5] [PMID: 32524333]

Debnath, M.; Banerjee, M.; Berk, M. Genetic gateways to COVID-19 infection: Implications for risk, severity, and outcomes. FASEB J., 2020, 34(7), 8787-8795.
[http://dx.doi.org/10.1096/fj.202001115R] [PMID: 32525600]

Hedayat, M.; Netea, M.G.; Rezaei, N. Targeting of Toll-like receptors: A decade of progress in combating infectious diseases. Lancet Infect. Dis., 2011, 11(9), 702-712.
[http://dx.doi.org/10.1016/S1473-3099(11)70099-8] [PMID: 21719349]

Brubaker, S.W.; Bonham, K.S.; Zanoni, I.; Kagan, J.C. Innate immune pattern recognition: A cell biological perspective. Annu. Rev. Immunol., 2015, 33(1), 257-290.
[http://dx.doi.org/10.1146/annurev-immunol-032414-112240] [PMID: 25581309]

Mohammad Hosseini, A.; Majidi, J.; Baradaran, B.; Yousefi, M. Toll-like receptors in the pathogenesis of autoimmune diseases. Adv. Pharm. Bull., 2015, 5(Suppl. 1), 605-614.
[http://dx.doi.org/10.15171/apb.2015.082] [PMID: 26793605]

Lee, J.; Wu, C.C.N.; Lee, K.J.; Chuang, T-H.; Katakura, K.; Liu, Y-T.; Chan, M.; Tawatao, R.; Chung, M.; Shen, C.; Cottam, H.B.; Lai, M.M.C.; Raz, E.; Carson, D.A. Activation of anti-hepatitis C virus responses via Toll-like receptor 7. Proc. Natl. Acad. Sci. USA, 2006, 103(6), 1828-1833.
[http://dx.doi.org/10.1073/pnas.0510801103] [PMID: 16446426]

Li, Z.J.; Sohn, K-C.; Choi, D-K.; Shi, G.; Hong, D.; Lee, H-E.; Whang, K.U.; Lee, Y.H. Im, M.; Lee, Y.; Seo, Y.J.; Kim, C.D.; Lee, J.H. Roles of TLR7 in activation of NF-κB signaling of keratinocytes by imiquimod. PLoS One, 2013, 8(10)e77159
[http://dx.doi.org/10.1371/journal.pone.0077159] [PMID: 24146965]

Tengroth, L.; Millrud, C.R.; Kvarnhammar, A.M.; Kumlien Georén, S.; Latif, L.; Cardell, L-O. Functional effects of Toll-like receptor (TLR)3, 7, 9, RIG-I and MDA-5 stimulation in nasal epithelial cells. PLoS One, 2014, 9(6)e98239
[http://dx.doi.org/10.1371/journal.pone.0098239] [PMID: 24886842]

Papatheodorou, I.; Fonseca, N.A.; Keays, M.; Tang, Y.A.; Barrera, E.; Bazant, W.; Burke, M.; Füllgrabe, A.; Fuentes, A.M-P.; George, N.; Huerta, L.; Koskinen, S.; Mohammed, S.; Geniza, M.; Preece, J.; Jaiswal, P.; Jarnuczak, A.F.; Huber, W.; Stegle, O.; Vizcaino, J.A.; Brazma, A.; Petryszak, R. Expression Atlas: gene and protein expression across multiple studies and organisms. Nucleic Acids Res., 2018, 46(D1), D246-D251.
[http://dx.doi.org/10.1093/nar/gkx1158] [PMID: 29165655]

Khanmohammadi, S.; Rezaei, N. Role of Toll-like receptors in the pathogenesis of COVID-19. J. Med. Virol., 2021, 93(5), 2735-2739.
[http://dx.doi.org/10.1002/jmv.26826] [PMID: 33506952]

Diebold, S.S.; Kaisho, T.; Hemmi, H.; Akira, S.; Reis e Sousa, C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science, 2004, 303(5663), 1529-1531.
[http://dx.doi.org/10.1126/science.1093616] [PMID: 14976261]

Lund, J.M.; Alexopoulou, L.; Sato, A.; Karow, M.; Adams, N.C.; Gale, N.W.; Iwasaki, A.; Flavell, R.A. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. USA, 2004, 101(15), 5598-5603.
[http://dx.doi.org/10.1073/pnas.0400937101] [PMID: 15034168]

Shen, N.; Fu, Q.; Deng, Y.; Qian, X.; Zhao, J.; Kaufman, K.M.; Wu, Y.L.; Yu, C.Y.; Tang, Y.; Chen, J-Y.; Yang, W.; Wong, M.; Kawasaki, A.; Tsuchiya, N.; Sumida, T.; Kawaguchi, Y.; Howe, H.S.; Mok, M.Y.; Bang, S-Y.; Liu, F-L.; Chang, D-M.; Takasaki, Y.; Hashimoto, H.; Harley, J.B.; Guthridge, J.M.; Grossman, J.M.; Cantor, R.M.; Song, Y.W.; Bae, S-C.; Chen, S.; Hahn, B.H.; Lau, Y.L.; Tsao, B.P. Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA, 2010, 107(36), 15838-15843.
[http://dx.doi.org/10.1073/pnas.1001337107] [PMID: 20733074]

Lee, Y.H.; Lee, H-S.; Choi, S.J.; Ji, J.D.; Song, G.G. Associations between TLR polymorphisms and systemic lupus erythematosus: A sys-tematic review and meta-analysis. Clin. Exp. Rheumatol., 2012, 30(2), 262-265.
[PMID: 22325161]

Tian, T.; Sun, D.; Wang, P.; Wang, H.; Bai, X.; Yang, X.; Wang, Z.; Dong, M. Roles of toll-like receptor 7 and 8 in prevention of intrauter-ine transmission of hepatitis B virus. Cell. Physiol. Biochem., 2015, 37(2), 445-453.
[http://dx.doi.org/10.1159/000430367] [PMID: 26315138]

Chang, S.; Kodys, K.; Szabo, G. Impaired expression and function of toll-like receptor 7 in hepatitis C virus infection in human hepatoma cells. Hepatology, 2010, 51(1), 35-42.
[http://dx.doi.org/10.1002/hep.23256] [PMID: 19821521]

Abdel-Raouf, T.A.; Ahmed, A.; Zaki, W.K.; Abdella, H.M.; Zid, M.A. Study of toll-like receptor 7 expression and interferon α in Egyptian patients with chronic hepatitis C infection and hepatocellular carcinoma. Egypt. J. Med. Hum. Genet., 2014, 15(4), 387-392.
[http://dx.doi.org/10.1016/j.ejmhg.2014.07.003]

Oh, D-Y.; Baumann, K.; Hamouda, O.; Eckert, J.K.; Neumann, K.; Kücherer, C.; Bartmeyer, B.; Poggensee, G.; Oh, N.; Pruss, A.; Jessen, H.; Schumann, R.R. A frequent functional toll-like receptor 7 polymorphism is associated with accelerated HIV-1 disease progression. AIDS, 2009, 23(3), 297-307.
[http://dx.doi.org/10.1097/QAD.0b013e32831fb540] [PMID: 19114863]

Fallerini, C.; Daga, S.; Mantovani, S.; Benetti, E.; Picchiotti, N.; Francisci, D.; Paciosi, F.; Schiaroli, E.; Baldassarri, M.; Fava, F.; Palmieri, M.; Ludovisi, S.; Castelli, F.; Quiros-Roldan, E.; Vaghi, M.; Rusconi, S.; Siano, M.; Bandini, M.; Spiga, O.; Capitani, K.; Furini, S.; Mari, F.; Renieri, A.; Mondelli, M.U.; Frullanti, E. Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study. eLife, 2021, 10e67569
[http://dx.doi.org/10.7554/eLife.67569] [PMID: 33650967]

Miettinen, M.; Sareneva, T.; Julkunen, I.; Matikainen, S. IFNs activate toll-like receptor gene expression in viral infections. Genes Immun., 2001, 2(6), 349-355.
[http://dx.doi.org/10.1038/sj.gene.6363791] [PMID: 11607792]

Lester, R.T.; Yao, X-D.; Ball, T.B.; McKinnon, L.R.; Kaul, R.; Wachihi, C.; Jaoko, W.; Plummer, F.A.; Rosenthal, K.L. Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infection. AIDS, 2008, 22(6), 685-694.
[http://dx.doi.org/10.1097/QAD.0b013e3282f4de35] [PMID: 18356597]

Komatsuda, A.; Wakui, H.; Iwamoto, K.; Ozawa, M.; Togashi, M.; Masai, R.; Maki, N.; Hatakeyama, T.; Sawada, K. Up-regulated expres-sion of Toll-like receptors mRNAs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Clin. Exp. Immunol., 2008, 152(3), 482-487.
[http://dx.doi.org/10.1111/j.1365-2249.2008.03646.x] [PMID: 18373699]

Sheyhidin, I.; Nabi, G.; Hasim, A.; Zhang, R-P.; Ainiwaer, J.; Ma, H.; Wang, H. Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma. World J. Gastroenterol., 2011, 17(32), 3745-3751.
[http://dx.doi.org/10.3748/wjg.v17.i32.3745] [PMID: 21990957]

Roelofs, M.F.; Joosten, L.A.B.; Abdollahi-Roodsaz, S.; van Lieshout, A.W.T.; Sprong, T.; van den Hoogen, F.H.; van den Berg, W.B.; Rad-stake, T.R.D.J. The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like re-ceptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells. Arthritis Rheum., 2005, 52(8), 2313-2322.
[http://dx.doi.org/10.1002/art.21278] [PMID: 16052591]

Yazdanpanah, F.; Hamblin, M.R.; Rezaei, N. The immune system and COVID-19: Friend or foe? Life Sci., 2020, 256117900
[http://dx.doi.org/10.1016/j.lfs.2020.117900] [PMID: 32502542]

Sooryanarain, H.; Rogers, A.J.; Cao, D.; Haac, M.E.R.; Karpe, Y.A.; Meng, X-J. ISG15 modulates type I interferon signaling and the antivi-ral response during hepatitis E virus replication. J. Virol., 2017, 91(19), e00621-e17.
[http://dx.doi.org/10.1128/JVI.00621-17] [PMID: 28724761]

Okumura, A.; Lu, G.; Pitha-Rowe, I.; Pitha, P.M. Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc. Natl. Acad. Sci. USA, 2006, 103(5), 1440-1445.
[http://dx.doi.org/10.1073/pnas.0510518103] [PMID: 16434471]

Mesev, E.V.; LeDesma, R.A.; Ploss, A. Decoding type I and III interferon signalling during viral infection. Nat. Microbiol., 2019, 4(6), 914-924.
[http://dx.doi.org/10.1038/s41564-019-0421-x] [PMID: 30936491]

Kee, B.P.; Lian, L.H.; Lee, P.C.; Lai, T.X.; Chua, K.H. Genetic data for 15 STR loci in a Kadazan-Dusun population from East Malaysia. Genet. Mol. Res., 2011, 10(2), 739-743.
[http://dx.doi.org/10.4238/vol10-2gmr1064] [PMID: 21523653]

Zeberg, H.; Pääbo, S. The major genetic risk factor for severe COVID-19 is inherited from Neanderthals. Nature, 2020, 587(7835), 610-612.
[http://dx.doi.org/10.1038/s41586-020-2818-3] [PMID: 32998156]

Li, Y.; Ke, Y.; Xia, X.; Wang, Y.; Cheng, F.; Liu, X.; Jin, X.; Li, B.; Xie, C.; Liu, S.; Chen, W.; Yang, C.; Niu, Y.; Jia, R.; Chen, Y.; Liu, X.; Wang, Z.; Zheng, F.; Jin, Y.; Li, Z.; Yang, N.; Cao, P.; Chen, H.; Ping, J.; He, F.; Wang, C.; Zhou, G. Genome-wide association study of COVID-19 severity among the Chinese population. Cell Discov., 2021, 7(1), 76.
[http://dx.doi.org/10.1038/s41421-021-00318-6] [PMID: 34465742]